Screener
Ionis Pharmaceuticals IONS Stock Issuance Proceeds
Stock Issuance Proceeds at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions.
The source filing: Ionis Pharmaceuticals’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 5:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000874015-26-000251
| Line item | Six Months Ended / June 30, 2026 | Six Months Ended / June 30, 2025 |
|---|---|---|
| Acquisition of licenses and other assets, net | (3,640) | (2,615) |
| Net cash provided by investing activities | 560,317 | 50,391 |
| Financing activities: | ||
| Proceeds from issuance of common stock through equity plans, net | 77,560 | 3,528 |
| Repayment of 0 percent convertible senior notes due 2026 | (432,511) | - |
| Principal payments on mortgage debt | (85) | (82) |
| Net cash provided by (used in) financing activities | (355,036) | 3,446 |
| Effects of exchange rates on cash | (188) | 827 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Ionis Pharmaceuticals's stock issuance proceeds?
- Ionis Pharmaceuticals (IONS) reported stock issuance proceeds of $20.26M in Q2 2026.
- How has Ionis Pharmaceuticals's stock issuance proceeds changed year-over-year?
- Ionis Pharmaceuticals's stock issuance proceeds increased by 1474.0% year-over-year, from $1.29M to $20.26M.
- What is the long-term trend for Ionis Pharmaceuticals's stock issuance proceeds?
- Over 4 years (2021 to 2025), Ionis Pharmaceuticals's stock issuance proceeds has grown at a -100.0% compound annual growth rate (CAGR), from $11.57M to $0.
- What does stock issuance proceeds mean?
- Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.
Ask your AI about Ionis Pharmaceuticals's stock issuance proceeds.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude